期刊文献+

脑钠肽前体与急性脑梗死危险因素的相关研究

Study on correlation between pro-brain natriuretic peptide and risk factors of acute cerebral ischemia
原文传递
导出
摘要 目的:探讨脑钠肽前体(pro-BNP)水平与急性脑梗死危险因素的关系。方法:检测并比较66名正常健康人与125例急性脑梗死患者发病后24 h内pro-BNP和C反应蛋白(CRP)水平。采用Pearson相关分析和多因素逐步回归分析pro-BNP水平与急性脑梗死常见危险因素的相关性。结果:与正常对照组相比,脑梗死组患者血pro-BNP和CRP水平显著升高[(48.72±13.44)ng/L比(267.03±131.83)ng/L,(4.14±5.27)mg/L比(30.96±24.53)mg/L,均P<0.01]。pro-BNP水平与脑梗死常见危险因素相关(P<0.01)。多因素逐步回归分析显示,pro-BNP水平随收缩压及CRP的增加而增加(偏回归系数分别为5.291和1.052,均P<0.01)。结论:pro-BNP水平与急性脑梗死患病显著相关,CRP和收缩压是影响pro-BNP水平的独立因素。 Objective To investigate whether the pro-brain natriuretic peptide (pro-BNP) might be associated withacute cerebral ischemia and cerebrovascular risk factors. Methods pro-BNP and C-reactive protein (CRP) level wereanalyzed and compaired in 66 healthy subjects and 125 patients with acute cerebral ischemia within 24 h after onset. Thecorrelation between the value of pro-BNP and the common risk factors of acute cerebral infarction was analyzed by Pearsoncorrelation analysis and multiple stepwise regression analysis. Results Compared with normal control group, pro-BNP andCRP in stroke group were significantly higher [(48.72±13.44) ng/L vs (267.03±131.83) ng/L, (4.14±5.27) mg/L vs(30.96±24.53) mg/L, all P〈0.01], and pro-BNP level was correlated with stroke risk factors (P〈0.01). Multiple stepwiseregression analysis showed that the level of pro-BNP increased with the increase of systolic blood pressure and CRP(partial regression coefficients were 5.291 and 1.052 respectively, all P〈0.01). Conclusions pro-BNP level wassignificantly associated with acute cerebral ischemia, CRP and systolic blood pressure were the main independent factorsthat might influence pro-BNP level.
出处 《内科理论与实践》 2014年第2期148-151,共4页 Journal of Internal Medicine Concepts & Practice
关键词 急性脑梗死 脑钠肽前体 C反应蛋白 收缩压 Acute cerebral ischemia Pro-brain natriuretic peptide C-reactive protein Systolic blood pressure
  • 相关文献

参考文献24

  • 1Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [J]. Circulation, 2009, 119(3): 480-486.
  • 2Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56population-based studies: a systematic review [J]. Lancet Neurol, 2009, 8(4): 355-369.
  • 3Tong J, Zhu Y, Jie J, et al. Analysis of current situation of Chinese health care reform by studying emergency overcrowding in a typical Shanghai hospital [J]. Am J Emerg Med, 2012, 30(7): 1313-1318.
  • 4Tufi6n J, Blanco-Colio L, Crist6bal C, et al. Usefulness of a combination of monocyte chemoattractant protein-l, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease [J]. Am J Cardiol, 2014, 113(3): 434-440.
  • 5Kim SA, Rhee S J, Shim CY, et al. prognostic value of N- terminal probrain natriuretic peptide level on admission in patients with acute myocardial infarction and pre- served left ventricular ejection fraction [J]. Coron Artery Dis, 2011, 22(3): 153-157.
  • 6Dini FL, Gabutti A, Passino C, et al. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as inde- pendent predictors of prognosis in systolic heart failure [J]. Int J Cardiol, 2010, 140(3): 344-350.
  • 7Nakagawa K, Yamaguchi T, Seida M, et al. Plasma con- centrations of brain natriuretie peptide in patients with a- cute ischemic stroke [J]. Cerebrovasc Dis, 2005, 19(3): 157-164.
  • 8Chen X, Zhan X, Chen M, et al. The prognostic value of combined NT-pro-BNP levels and NIHSS scores in pa- tients with acute isehemic stroke [J]. Intern Med, 2012, 51(20): 2887-2892.
  • 9Lewis LK, Raudsepp SD, Yandle TG, et al. Comparison of immunoassays for NTproBNP conducted on three anal- ysis systems: Milliplex, Elecsys and RIA [J]. Clin Biochem, 2013, 46(4/5): 388-390.
  • 10Adams HP Jr, del Zoppo G, Alberts M J, et al. Guide- lines for the early management of adults with ischemic stroke [J]. Circulation, 2007, 115(20): E478-E534.

二级参考文献29

  • 1周伟君,童建菁,叶静,陆一鸣.超敏C-反应蛋白与脑血管疾病危险因素的相关性研究[J].中国危重病急救医学,2007,19(6):325-328. 被引量:42
  • 2Elkind M S. Inflammation, atherosclerosis, and stroke[J]. Neurologist, 2006,12(3): 140- 148.
  • 3Adams H P Jr, Adams R J, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association[J]. Stroke,2003,34(4):1056- 1083.
  • 4Broderick J P, Adams H P Jr, Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association[J]. Stroke, 1999,30(4) :905-915.
  • 5Masotti L, Ceccarelli E, Forconi S, et al. Prognostic role of Creactive protein in very old palients with acute ischaemie stroke[J]. J Intern Med,2005,258(2):145 -152.
  • 6Hamidon B B, Sapiah S, Nawawi H, et al. The prognostic value of C reactive protein (CRP) levels in patients with acute ischaemic stroke[J]. Med J Malaysia,2004,59(5):631 -637.
  • 7Bassuk S S, Rifai N, Ridker P M. High sensitivity C-reactive protein: clinical importance[J], Curr Probl Cardiol, 2004,29 (8) :439-493.
  • 8Christensen H, Boysen G. C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke[J]. Cerebrovasc Dis,2004,18(3):214-219.
  • 9Bassuk S S,Rifai N,Ridker P M. High -sensitivity C- reactive protein : clinical importance [J]. Curr Probl Cardiol, 2004,29 (8) : 439 - 493.
  • 10Ridker P M. High - sensitivity C - reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease [J]. Circulation, 2001,103 ( 13 ) : 1813 - 1818.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部